Immunologic determinants of mammary tumors: PD-L1 and TILS Pedro Eduardo Dacosta; Lourdes Naranjo; Vicente Peg;

Prognostic value of tumor-infiltrating lymphocytes (TILS) and their association with clinicopathological features in breast cancer: A retrospective study involving 53 cases Oussama Belkacem; Dhouha Bacha; Nabil Rahoui; Mohamed Dhia Zran; Ahlem Lahmar; Sana Ben Slama;

Predictive value of tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer patients treated with neoadjuvant chemotherapy Hayam E. Rashed; Shireen S. Muhammad; Reham Sameh; Eman Elsebai; Nashwa Nawar; Mohamed I. Abdelhamid; Lobna A. Abdelaziz;